Clinical trials
Observational Multiple Myeloma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Unknown status | 8 |
| Completed | 4 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| FengYan Jin | 4 |
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Zhujiang Hospital | 4 |
| Takeda | 3 |
| RenJi Hospital | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Shanxi Bethune Hospital | 2 |
| Beijing Chao Yang Hospital | 1 |
| Celgene | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 39 |
| Neoplasm, Residual | 7 |
| Lymphoma | 4 |
| Myelodysplastic Syndromes | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Monoclonal Gammopathy of Undetermined Significance | 3 |
| Anemia, Aplastic | 2 |
| Hemophilia A | 2 |
| Hemostatic Disorders | 2 |
| Leukemia | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.